News Daily News Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis Michael O'Riordan January 24, 2018
News Daily News High Rate of Clinical Events at 6 Months for Ischemic CVD Patients Michael O'Riordan January 19, 2018
News Daily News Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward Michael O'Riordan January 09, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors Michael O'Riordan December 12, 2017
News Daily News It’s Official: Evolocumab Gains Claim for CVD Event Reduction Michael O'Riordan December 04, 2017
News Daily News Genetic Study Hints at Role of Lipids in AAA Risk Michael O'Riordan November 30, 2017
News Conference News AHA 2017 Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events Michael O'Riordan November 17, 2017
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Daily News Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients Michael O'Riordan October 26, 2017
News Daily News More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA Michael O'Riordan October 24, 2017
News Daily News Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests Michael O'Riordan October 20, 2017
News Daily News Evolocumab ‘Abjectly Fails’ Another Financial Stress Test Michael O'Riordan October 19, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2017 Caitlin E. Cox August 31, 2017
News Conference News ESC 2017 Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed Michael O'Riordan August 29, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Daily News ‘Remnant’ Cholesterol Linked With CVD Risk, Even When LDL Levels Are Low Michael O'Riordan August 01, 2017
News Daily News Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke Michael O'Riordan July 25, 2017
News Daily News Hormone Therapies May Have Adverse CV Effects in Transgender Adults Ashley Lyles July 24, 2017